Video Gallery

About this Video

Mr. Stéphane Bancel joined Moderna in the summer of 2011 when it was a one employee company. He has assembled a world-class team and raised more than $1Billion between equity financing and upfront from licensing collaborations. Hear directly from Mr. Bancel about what it takes to be CEO of such a rapidly growing company.

Stéphane Bancel is the CEO of Moderna, a pharmaceutical company that is pioneering the development of a new class of drugs made of messenger RNA (mRNA). He was previously CEO of bioMérieux, a world leader in the diagnostics industry. bioMerieux has more than 6,000 employees, a market capitalization of €2.5 billion, and sales of more than €1.3 billion. He holds a Master of Engineering from École Central Paris, a Master of Science in Chemical Engineering from the University of Minnesota and an MBA from Harvard Business School. Mr. Bancel was elected a 2009 Young Global Leader by the World Economic Forum. He was elected best CEO for investor relations in France in 2009 and was ranked the number one CEO in the biotech sector according to the 2011 Thomson Reuters EXTEL Study. Mr. Bancel serves as a supervisory director of Qiagen N.V., and on the Board of Directors of Syros Pharmaceuticals.

About the Speaker

Stephane Bancel

Stephane Bancel

Stephane Bancel is the founding CEO of Moderna Therapeutics in Cambridge MA.